Published in Genetics and Environmental Law Weekly, November 29th, 2008
All funds to support patients will be provided exclusively by pharmaceutical manufacturers. No dollars donated to the CF Foundation will be used for patient assistance. CF Foundation donations will continue to support research for a cure.
"Treatment costs are escalating beyond many cystic fibrosis patients' ability to pay," said Robert J. Beall, Ph.D., President and CEO of the Foundation. "Thanks to remarkable advances in research and care,...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Genetics and Environmental Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.